28 results
8-K
EX-99.1
ACXP
Acurx Pharmaceuticals, Inc.
9 Aug 24
Acurx Pharmaceuticals, Inc. Reports Second Quarter 2024 Results and Provides Business Update
7:13am
the quarter of $0.4 million, partially offset by a reduction in consulting fees of $0.3 million. For the six months ended June 30, 2024 research & development … increase in manufacturing related costs offset by $0.2 million decrease in consulting fees.
G&A Expenses:
General and administrative expenses
RW
ACXP
Acurx Pharmaceuticals, Inc.
17 Apr 24
Registration withdrawal request
4:05pm
to the Commission in connection with the filing of the Registration Statement be credited to the Company’s account to be offset against the filing fee for any future
8-K
EX-99.1
yko 3n7g09
14 Nov 23
Acurx Pharmaceuticals, Inc. Reports Third Quarter 2023 Results and Provides Business Update
4:05pm
8-K
EX-99.1
wrub7j0e
14 Aug 23
Acurx Pharmaceuticals, Inc. Reports Second Quarter 2023 Results and Provides Business Update
7:10am
8-K
EX-99.1
42c157
14 Nov 22
Acurx Pharmaceuticals, Inc. Reports Third Quarter 2022 Results and Provides Business Update
7:11am
8-K
EX-99.1
i537dv
15 Aug 22
Acurx Pharmaceuticals, Inc. Reports Second Quarter 2022 Results and Provides
4:19pm
8-K
EX-99.1
dj7fujtt8or3m8jq
17 Mar 22
Acurx Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2021 Results and Provides Business Update
7:17am
10-K
egv1gnwp mwisij8d
16 Mar 22
Annual report
4:05pm